In this report, we revealed that HIF‐1α and ZEB1 in the hypoxic tumor microenvironments would be new potential biomarkers for ACs and then the secondary induced TGF‐β to which EMT induction was dependent would be a critical clinical target for the AC therapy. The gene discussed is HIF1A; the disease is neoplasm.